1. Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.116
Figure 3 Valve haemodynamics and paravalvular aortic regurgitation after TAVI
Figure 3 | Valve haemodynamics and paravalvular aortic regurgitation after TAVI. a | Aortic valve (AV) areas at baseline and after transcatheter AV implantation (TAVI) or surgical AV replacement (SAVR) in the PARTNER 2 trial5, which included 2,032 patients at intermediate surgical risk. b | Paravalvular regurgitation after TAVI or SAVR in the PARTNER 2 trial5. c | AV areas and mean transvalvular gradients at baseline or after TAVI or SAVR in the SURTAVI trial6, which included 1,660 patients at intermediate surgical risk. d | Paravalvular regurgitation after TAVI or SAVR in the SURTAVI trial6. Data in panels a and b obtained from Ref. 5. Data in panels c and d obtained from Ref. 6.
Puri, R. et al. (2017) Future of transcatheter aortic valve implantation — evolving clinical indications
Nat. Rev. Cardiol. doi: /nrcardio